Clinical trial Recruiting at 2 sites Phase 2 Interventional Ages 21 and up

Reducing nicotine levels in cigarettes and e-cigarettes for dual users

Official title: A Randomized Controlled Trial of Reduced Nicotine Cigarettes and E-cigarettes Among Dual Users

Run by University of Vermont · NCT06614504 · Data updated 2026-11-12

This study tests if lowering nicotine levels in cigarettes and e-cigarettes can help people who use both cut down on their tobacco use and cravings.

Quick facts

PhasePhase 2
Study typeInterventional
Ages21 Years and up
SexAll
Enrollment308 (estimated)
SponsorUniversity of Vermont
Academic / other
Locations2 sites (Providence, Rhode Island and 1 other locations)
StatusRecruiting
StartedNovember 1, 2024
Main results expectedAugust 31, 2028
Study endsSeptember 30, 2028
Registry record updatedJune 27, 2025
Trial IDNCT06614504 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21 and older who regularly use both cigarettes and e-cigarettes.

Probably not a fit

Patients who are pregnant, under 21, or have health conditions that could interfere with study participation may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of varying nicotine content in both cigarettes and e-cigarettes on individuals who use both products. It aims to understand how reducing nicotine levels can help dual users decrease their tobacco consumption and dependence. Participants will be randomized to receive different nicotine levels to assess their smoking behavior and cravings. The study is motivated by the FDA's plans to limit nicotine in cigarettes, which could potentially lead to reduced tobacco-related harm.

Why it matters

Potential benefit: If successful, this approach could help dual users of e-cigarettes and cigarettes reduce their tobacco use and dependence, leading to better health outcomes.

How similar studies have gone: Previous randomized controlled trials have shown success with very low nicotine content cigarettes in reducing smoking behavior, indicating potential for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Regular use of tobacco
* 21 year of age or older
* Speak, comprehend and read English well enough to complete study procedures

Exclusion Criteria:

* Pregnant, trying to become pregnant, or nursing
* Under the age of 21
* Health conditions that could undermine ability to complete the study

Where it's running

  • Brown University
    Providence, Rhode Island, United States
    Recruiting
  • University of Vermont
    Burlington, Vermont, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Personalized brain-targeted TMS for smoking cessation

    A personalized brain-guided Transcranial Magnetic Stimulation (TMS) approach is tested against a standard TMS method to see if it better changes reward brain activity and reduces cravings and smoking in adults with tobacco use disorder.

    Recruiting Rutgers, The State University of New Jersey · Newark, New Jersey · NCT07812753

  • Multilevel program to increase LDCT lung cancer screening and help African American smokers quit

    This program will try combining low-dose CT screening with culturally tailored smoking-cessation support to help African American smokers who are eligible for LDCT quit and get screened.

    Recruiting at 2 sites Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana and 1 other locations · NCT07576595

  • TUBSIS 2.0 — an online program to help adults reduce or quit smoking and vaping

    This program tests whether a free, anonymous, 4-week web-based course using mindfulness, self-compassion, and behavior-change techniques helps German-, English-, and Turkish-speaking adults who smoke or vape reduce or quit tobacco.

    Recruiting University of Zurich · Zurich · NCT07568483

  • Impact of Menthol vs. Non-Menthol Cigarettes on Abuse Liability

    This study tests whether menthol cigarettes have different abuse potential than non-menthol cigarettes in menthol cigarette users, using a within-subject design across lab sessions and daily diaries.

    Recruiting Ohio State University Comprehensive Cancer Center · Columbus, Ohio · NCT07564648

  • Ear acupressure plus nicotine replacement to ease withdrawal in psychiatric inpatients

    This study will test whether adding ear acupressure (ear seeds) to standard nicotine replacement therapy helps psychiatric inpatients who must stop smoking reduce withdrawal symptoms, cravings, and anxiety.

    Recruiting TsaoTun Psychiatric Center, Department of Health, Taiwan · Nantou City · NCT07466875

  • Facilitating Tobacco Treatment in Veterans with Serious Mental Illness

    This project tests an external facilitation approach to help VA clinics prescribe smoking medications more often to Veterans with serious mental illness who smoke.

    Recruiting VA Office of Research and Development · Baltimore, Maryland · NCT07455526

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.